ConferencePoster
 

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses

Wang, Xuya; GARRIDO, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan et al.